CreativeOne Wealth’s Definium Therapeutics DFTX Stock Holding History

CreativeOne Wealth’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,455	Closed	-$67K	–	1155
2025 Q1	$67K	Buy	+11,455	New	+$82K	﹤0.01%	1041
2024 Q4	–	Sell	-12,462	Closed	-$70.9K	–	1104
2024 Q3	$70.9K	Sell	12,462 -4,382	-26%	-$30.5K	﹤0.01%	933
2024 Q2	$121K	Buy	+16,844	New	+$147K	0.01%	749

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CreativeOne Wealth's DFTX Position: Q2 2025 in Review

CreativeOne Wealth sold out of Definium Therapeutics (DFTX) in Q2 2025, closing a stake of 11,455 shares — an estimated $67K sold.

CreativeOne Wealth first reported a position in DFTX in Q2 2024 and held it in 3 quarters. The position peaked at $121K in Q2 2024. 181 funds tracked by Wall St. Rank hold DFTX as of Q2 2025.

CreativeOne Wealth reported no remaining Definium Therapeutics position as of Q2 2025 after selling out during the quarter.
CreativeOne Wealth sold 11,455 Definium Therapeutics shares in Q2 2025, an estimated $67K.
CreativeOne Wealth first reported a position in Definium Therapeutics in Q2 2024 and held it in 3 quarters.
CreativeOne Wealth's Definium Therapeutics position peaked at $121K in Q2 2024.
181 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2025.

Based on CreativeOne Wealth's 13F filing for Q2 2025, filed 12 Aug 2025.